Health
NIH-Moderna Investigational COVID-19 Vaccine Shows Promise – SciTechDaily
Vaccine shows promise in mouse studies and is currently being evaluated in Phase 3 clinical testing. The investigational vaccine known as mRNA-1273 protected mice from infection with SARS-CoV-2, the virus that causes COVID-19, according to research published …
Colorized scanning electron micrograph of a VERO E6 cell (blue) heavily infected with SARS-COV-2 virus particles (orange), isolated from a patient sample. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID
Vaccine shows promise in mouse studies and is currently being evaluated in Phase 3 clinical testing.
The investigational vaccine known as mRNA-1273 protected mice from infection with SARS-CoV-2, the virus that causes COV…
-
Business24 hours agoWhy Amotiv, Breville, Life360, and Woodside shares are tumbling today
-
Noosa News23 hours agoDingoes bite 3 women on K’gari
-
Noosa News15 hours agoBrisbane doctor jailed for trafficking ‘breathtaking amount’ of drugs
-
Noosa News23 hours agoNoosa MP calls for solutions to curb reckless electric bike usage